NPPB and metabolic syndrome: However, near-normal levels of NT-proBNP associated with obesity, metabolic syndrome, and T2DM appear to have limited utility in predicting adverse cardiac remodeling, the transition to HFpEF, and the incidence of HFpEF [42].